214 related articles for article (PubMed ID: 15157211)
21. Biochemical characterization of in vivo alkylating agent resistance of a murine EMT-6 mammary carcinoma. Implication for systemic involvement in the resistance phenotype.
Chen G; Teicher BA; Frei E
Cancer Biochem Biophys; 1998 Jun; 16(1-2):139-55. PubMed ID: 9923973
[TBL] [Abstract][Full Text] [Related]
22. The effect of platinum analogues and combination chemotherapy on murine bladder cancer.
Soloway MS; Cox CE
Trans Am Assoc Genitourin Surg; 1979; 71():8-13. PubMed ID: 545820
[TBL] [Abstract][Full Text] [Related]
23. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
[TBL] [Abstract][Full Text] [Related]
24. Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells.
Stordal BK; Davey MW; Davey RA
Cancer Chemother Pharmacol; 2006 Aug; 58(2):256-65. PubMed ID: 16283310
[TBL] [Abstract][Full Text] [Related]
25. Resistance to cisplatin.
Akiyama S; Chen ZS; Sumizawa T; Furukawa T
Anticancer Drug Des; 1999 Apr; 14(2):143-51. PubMed ID: 10405641
[TBL] [Abstract][Full Text] [Related]
26. Response of nude mouse-grown human urothelial cancer to cis-diamminedichloroplatinum(II), diammine[1,1-cyclobutanedicarboxylato(2-)-O,O'-platinum], and mitoguazone dihydrochloride.
Kyriazis AP; Yagoda A; Kyriazis AA; Fogh J
Cancer Res; 1985 May; 45(5):2012-5. PubMed ID: 3886128
[TBL] [Abstract][Full Text] [Related]
27. [Examination of resistance of lung adenocarcinoma cells to cisplatin by technetium-99m methoxyisobutyl isonitrile].
Hu S; Hu CP; Liang CH
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1493-8. PubMed ID: 16061030
[TBL] [Abstract][Full Text] [Related]
28. Preclinical antitumor activity of the oral platinum analog satraplatin.
Wosikowski K; Lamphere L; Unteregger G; Jung V; Kaplan F; Xu JP; Rattel B; Caligiuri M
Cancer Chemother Pharmacol; 2007 Sep; 60(4):589-600. PubMed ID: 17541592
[TBL] [Abstract][Full Text] [Related]
29. Ultrastructural change due to acquired cisplatin resistance in human bladder cancer cells.
Yoon SJ; Park I; Kwak C; Lee E
Oncol Rep; 2003; 10(5):1363-7. PubMed ID: 12883708
[TBL] [Abstract][Full Text] [Related]
30. Chemoimmunotherapy of murine bladder cancer.
Stogdill BJ; Lamm DL; Livingston RB
Invest Urol; 1981 Nov; 19(3):179-81. PubMed ID: 7298287
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of cisplatin-resistance by RNA interference targeting metallothionein using reducible oligo-peptoplex.
Lee JH; Chae JW; Kim JK; Kim HJ; Chung JY; Kim YH
J Control Release; 2015 Oct; 215():82-90. PubMed ID: 26210439
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of DNA methyltransferase reverses cisplatin induced drug resistance in murine neuroblastoma cells.
Qiu YY; Mirkin BL; Dwivedi RS
Cancer Detect Prev; 2005; 29(5):456-63. PubMed ID: 16185816
[TBL] [Abstract][Full Text] [Related]
33. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
O'Malley BW; Li D; McQuone SJ; Ralston R
Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
[TBL] [Abstract][Full Text] [Related]
34. Cisplatin-resistant bladder carcinoma cells: enhanced expression of metallothioneins.
Siegsmund MJ; Marx C; Seemann O; Schummer B; Steidler A; Toktomambetova L; Köhrmann KU; Rassweiler J; Alken P
Urol Res; 1999 Jun; 27(3):157-63. PubMed ID: 10422815
[TBL] [Abstract][Full Text] [Related]
35. Cystathionine gamma-lyase contributes to selenomethionine detoxification and cytosolic glutathione peroxidase biosynthesis in mouse liver.
Okuno T; Ueno H; Nakamuro K
Biol Trace Elem Res; 2006 Feb; 109(2):155-71. PubMed ID: 16444005
[TBL] [Abstract][Full Text] [Related]
36. Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters.
Samimi G; Howell SB
Cancer Chemother Pharmacol; 2006 Jun; 57(6):781-8. PubMed ID: 16170571
[TBL] [Abstract][Full Text] [Related]
37. Induction of metallothionein synthesis in transplanted murine tumors by X irradiation.
Shibuya K; Satoh M; Muraoka M; Watanabe Y; Oida M; Shimizu H
Radiat Res; 1995 Jul; 143(1):54-7. PubMed ID: 7597144
[TBL] [Abstract][Full Text] [Related]
38. Curcumin prevents intravesical tumor implantation of the MBT-2 tumor cell line in C3H mice.
Sindhwani P; Hampton JA; Baig MM; Keck R; Selman SH
J Urol; 2001 Oct; 166(4):1498-501. PubMed ID: 11547120
[TBL] [Abstract][Full Text] [Related]
39. Erythropoietin modulates the anticancer activity of chemotherapeutic drugs in a murine lung cancer model.
Sigounas G; Sallah S; Sigounas VY
Cancer Lett; 2004 Oct; 214(2):171-9. PubMed ID: 15363543
[TBL] [Abstract][Full Text] [Related]
40. Effect of D,L-propargylglycine on cystathionine metabolism in rats.
Awata S; Nakayama K; Kodama H
Biochem Int; 1984 Jan; 8(1):171-9. PubMed ID: 6477595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
